Clinical Trial Update: Combination Antibiotic Therapy for Methicillin Resistant Staphylococcus Aureus Infection [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating a combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methicillin-resistant Staphylococcus Aureus Infection

Snippet

Sponsor: Menzies School of Health Research | Conditions: Methicillin-Resistant Staphylococcus Aureus | Phase 3 | Status: TERMINATED